HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

François Aubin Selected Research

Solar Urticaria

3/2016Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study.
11/2015No major effect of cyclosporin A in patients with severe solar urticaria: a french retrospective case series.
11/2014Severe and refractory solar urticaria treated with intravenous immunoglobulins: a phase II multicenter study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


François Aubin Research Topics

Disease

23Melanoma (Melanoma, Malignant)
10/2022 - 05/2006
20Psoriasis (Pustulosis Palmaris et Plantaris)
01/2021 - 01/2006
11Neoplasms (Cancer)
01/2022 - 06/2002
4Carcinogenesis
01/2021 - 06/2002
4Merkel Cell Carcinoma
11/2020 - 04/2011
4Inflammation (Inflammations)
01/2020 - 01/2002
4Hidradenitis Suppurativa
01/2020 - 01/2016
3Autoimmune Diseases (Autoimmune Disease)
10/2022 - 01/2006
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2021 - 06/2002
3Lung Neoplasms (Lung Cancer)
10/2020 - 05/2016
3Rheumatoid Arthritis
01/2020 - 09/2014
3Vitiligo
01/2020 - 01/2016
3Crohn Disease (Crohn's Disease)
01/2020 - 01/2016
3Infections
10/2016 - 04/2011
3Solar Urticaria
03/2016 - 11/2014
3Lymphoma (Lymphomas)
01/2015 - 01/2014
3Skin Neoplasms (Skin Cancer)
01/2015 - 01/2004
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
11/2022 - 03/2014
2Myositis (Idiopathic Inflammatory Myopathies)
11/2022 - 12/2021
2Uveal melanoma
12/2020 - 01/2018
2Atopic Dermatitis (Atopic Eczema)
01/2020 - 07/2019
2Fibrosis (Cirrhosis)
01/2020 - 07/2007
2Fever (Fevers)
01/2020 - 10/2016
2Necrosis
11/2019 - 01/2016
2Contact Dermatitis (Eczema, Contact)
09/2019 - 01/2002
2Acquired Hyperostosis Syndrome (SAPHO Syndrome)
12/2017 - 06/2012
2Kidney Neoplasms (Kidney Cancer)
09/2017 - 10/2011
2Ankylosing Spondylitis
08/2016 - 03/2013
2Alopecia Areata
01/2016 - 06/2014
2Sarcoidosis (Schaumann Disease)
01/2016 - 11/2007
2Bullous Pemphigoid (Pemphigoid)
12/2015 - 01/2014
2Carcinoma (Carcinomatosis)
05/2015 - 11/2014
1Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris)
01/2022
1IgA Vasculitis (Purpura, Schoenlein Henoch)
01/2022
1Insulin Resistance
01/2021
1Hepatocellular Carcinoma (Hepatoma)
12/2020
1Renal Cell Carcinoma (Grawitz Tumor)
10/2020
1Squamous Cell Carcinoma of Head and Neck
10/2020
1Head and Neck Neoplasms (Head and Neck Cancer)
10/2020
1Immediate Hypersensitivity
02/2020
1Disease Progression
01/2020
1Exanthema (Rash)
01/2020

Drug/Important Bio-Agent (IBA)

10Immune Checkpoint InhibitorsIBA
10/2022 - 09/2017
7Infliximab (Remicade)FDA Link
01/2020 - 07/2009
6pembrolizumabIBA
11/2022 - 01/2019
6Ustekinumab (CNTO 1275)FDA Link
09/2019 - 02/2014
5Adalimumab (Humira)FDA Link
09/2019 - 02/2014
5Monoclonal AntibodiesIBA
06/2019 - 06/2008
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 05/2008
5Tumor Necrosis Factor InhibitorsIBA
01/2016 - 12/2012
4IpilimumabIBA
10/2020 - 01/2012
4Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 09/2014
4Interleukin-17 (Interleukin 17)IBA
11/2019 - 12/2015
4Etanercept (Enbrel)FDA Link
09/2019 - 05/2008
4Biological ProductsIBA
09/2019 - 06/2016
3AntibodiesIBA
01/2020 - 12/2008
3Proteins (Proteins, Gene)FDA Link
11/2019 - 06/2002
3DNA (Deoxyribonucleic Acid)IBA
10/2009 - 06/2002
2Immune Checkpoint ProteinsIBA
01/2022 - 09/2017
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2022 - 05/2016
2AdipokinesIBA
01/2021 - 01/2014
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2020 - 01/2017
2dupilumabIBA
01/2020 - 07/2019
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2020 - 06/2012
2CytokinesIBA
01/2020 - 12/2015
2ImmunosorbentsIBA
01/2020 - 11/2019
2EnzymesIBA
01/2020 - 11/2019
2Interleukin-10 (Interleukin 10)IBA
01/2020 - 11/2019
2Interleukin-6 (Interleukin 6)IBA
01/2020 - 11/2019
2InterleukinsIBA
11/2019 - 06/2018
2Local Anti-Infective Agents (Antiseptics)IBA
09/2019 - 01/2016
2Pharmaceutical PreparationsIBA
09/2019 - 05/2008
2secukinumabIBA
06/2018 - 12/2017
2Interleukin-23 (Interleukin 23)IBA
12/2017 - 12/2015
2Papillomavirus Vaccines (HPV Vaccines)IBA
01/2016 - 05/2015
2Messenger RNA (mRNA)IBA
01/2015 - 01/2014
2efalizumab (Raptiva)FDA Link
02/2012 - 06/2008
2Interferon-alpha (Interferon Alfa)IBA
04/2011 - 11/2007
1CeramidesIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1cemiplimabIBA
07/2021
1ResistinIBA
01/2021
1Oncogene Proteins (Oncogene Protein)IBA
01/2021
1LeptinIBA
01/2021
1Vitamin A (Retinol)FDA LinkGeneric
01/2021
1Insulin (Novolin)FDA Link
01/2021
1AdiponectinIBA
01/2021
1NivolumabIBA
10/2020
1LigandsIBA
10/2020
1Coloring Agents (Dyes)IBA
02/2020
1N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA
01/2020
1Immunoglobulin M (IgM)IBA
01/2020
1Immunoglobulin G (IgG)IBA
01/2020
1Immunoglobulin A (IgA)IBA
01/2020
1N 30IBA
01/2020

Therapy/Procedure

21Therapeutics
11/2022 - 11/2007
8Immunotherapy
01/2022 - 01/2012
3Drug Therapy (Chemotherapy)
10/2020 - 05/2003
2Transplantation
03/2014 - 07/2007
1Oral Administration
02/2020